Multi-component Family Intervention to Lower Depression and Address Intimate Partner Violence in Nepal
Launched by POSSIBLE · Feb 13, 2025
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach called the Multi-component Family Intervention to Lower depression and Address Intimate Partner Violence (MILAP) in Nepal. Intimate Partner Violence (IPV) is a serious issue that affects many women and can lead to mental health problems like depression and PTSD. The trial aims to see if involving not just women, but also their husbands and mothers-in-law in the treatment can help reduce IPV and improve mental health for young married women aged 15-24 who have experienced violence in the past year.
To be eligible for this study, participants must be married women living with their husbands and mothers-in-law in the same household, speak Maithili or Nepali, and have experienced some form of IPV recently. Participants will be divided into two groups: one will receive the MILAP intervention, while the other will get standard care. They will answer questions about their mental health and experiences with IPV at the start of the study, after one month, and every three months for a year. This trial is not yet recruiting, but it holds promise for helping families in Nepal address both IPV and mental health issues together.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Married women aged 15-24 years, their husbands and MILs sharing a household;
- • Living in the catchment area with no stated intention of leaving during the study period;
- • Participants speaking in Maithili or Nepali;
- • Wife reporting Intimate Partner Violence (physical, sexual or abusive control) in last 12 months as measured by three questions from the International Violence Against Women Survey (IVAWS);
- • Expressing desire to remain in the current relationship/family
- Exclusion Criteria:
- • Pregnant women;
- • History of IPV severe enough to result in hospitalization in the past 12 months;
- • Significant cognitive problems/disability precluding participation;
- • Any participant with Severe Alcohol Dependence, defined as Severity of Alcohol Dependence Questionnaire (SADQ) \> 31 (those with mild to moderate dependance will be referred but not excluded)
About Possible
Possible is a forward-thinking clinical trial sponsor dedicated to advancing medical research and improving patient outcomes. With a focus on innovative therapies, Possible collaborates with healthcare professionals, researchers, and regulatory bodies to design and execute robust clinical trials across various therapeutic areas. Leveraging cutting-edge technology and a patient-centered approach, Possible strives to enhance trial efficiency, ensure compliance, and ultimately bring safe and effective treatments to market. Committed to transparency and ethical practices, Possible is at the forefront of transforming the landscape of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kathmandu, Bagmati, Nepal
Patients applied
Trial Officials
Bibhav Acharya, MD
Principal Investigator
University of California, San Francisco
Sabitri Sapkota, PhD
Principal Investigator
Possible
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported